Our Services
Medical Information
Helpful Resources
Published on: 9/12/2026
A low eGFR does not automatically mean you will need dialysis, and many people with reduced kidney function remain stable for years with the right treatment. Dialysis is generally only discussed when eGFR drops below about 15 and symptoms such as severe fatigue, swelling, nausea, or shortness of breath develop. Your outlook depends on several factors, including how quickly your eGFR is changing, protein in your urine, blood pressure, blood sugar control, and the medications you take, so review the complete answer below before drawing conclusions.
Because kidney disease often progresses quietly, tracking your symptoms early is one of the most useful things you can do between lab tests and appointments. Take a free, instant, online symptom check to see what your symptoms may indicate and get clear guidance on the right next steps to discuss with your doctor.
Last reviewed for medical accuracy: 09/12/2026
Estimated glomerular filtration rate (egfr) is a key measure of how well your kidneys filter waste from your blood. It’s calculated from blood creatinine levels, age, sex and sometimes race. Doctors use egfr to:
A low egfr doesn’t automatically mean you’ll need dialysis. Instead, it signals reduced kidney function that may or may not progress.
Normal egfr is roughly 90–120 mL/min/1.73 m². The National Kidney Foundation classifies egfr stages as:
Keep in mind:
Several factors can lower egfr:
Low egfr often reflects a combination of these factors. Addressing root causes can slow—or sometimes partially reverse—decline.
Dialysis replaces kidney filtering when waste products build up to dangerous levels. But reaching that point depends on:
Key points:
Signs it may be time to discuss dialysis:
If you’re asymptomatic and egfr is stable, many nephrologists focus on monitoring and medical management rather than immediate dialysis.
If your egfr is low but not yet in the dialysis-range, your care plan may include:
Blood Pressure Control
Blood Sugar Management (for diabetics)
Proteinuria Reduction
Avoiding Nephrotoxins
Anemia and Mineral Bone Disorder Management
Small changes can make a big difference:
• Diet
• Fluid Intake
• Exercise
• Smoking Cessation
Regular check-ups and lab tests help track trends. If you notice changes in urine output, swelling, or new symptoms, contact your healthcare provider promptly.
Even if dialysis isn’t imminent, pre-dialysis education and planning can reduce stress:
This preparation doesn’t mean you’ll definitely start dialysis soon. It ensures:
Learning your egfr is low can be stressful. It’s normal to feel:
Support strategies:
If you’re noticing new or worsening symptoms, you might consider doing a free, online symptom check, using the doctor approved Ubie Symptom Checker. This tool can help you identify possible causes and guide your next steps.
If you experience any of the following, speak to a doctor right away:
Always consult your healthcare team before making decisions about kidney care. If you have concerns about your egfr, symptoms or treatment plan, schedule an appointment with a nephrologist or your primary doctor.
(References)
* Bonnéric S, Karadkhele G, Couchoud C, Patzer RE, Greenbaum LA, Hogan J. Sex and Glomerular Filtration Rate Trajectories in Children. Clin J Am Soc Nephrol. 2020 Mar 6;15(3):320-329. doi: 10.2215/CJN.08420719. Epub 2020 Feb 28. PMID: 32111703; PMCID: PMC7057295.
* Qin A, Liu X, Ainiwaer M, Wang S, Tang Y, Qin W. Development and validation of a novel score to predict dialysis inadequacy in continuous ambulatory peritoneal dialysis patients. J Int Med Res. 2021 Jan;49(1):300060520984591. doi: 10.1177/0300060520984591. PMID: 33472494; PMCID: PMC7829543.
* Fu EL, Evans M, Carrero JJ, Putter H, Clase CM, Caskey FJ, Szymczak M, Torino C, Chesnaye NC, Jager KJ, Wanner C, Dekker FW, van Diepen M. Timing of dialysis initiation to reduce mortality and cardiovascular events in advanced chronic kidney disease: nationwide cohort study. BMJ. 2021 Nov 29;375:e066306. doi: 10.1136/bmj-2021-066306. Epub 2021 Nov 29. PMID: 34844936; PMCID: PMC8628190.
* Wang IK, Yen TH, Tsai CH, Sun Y, Chang WL, Chen PL, Lai TC, Yeh PY, Wei CY, Lin CL, Hsu KC, Li CY, Sung FC, Hsu CY, Taiwan Stroke Registry Investigators. Renal function is associated with one-month and one-year mortality in patients with intracerebral hemorrhage. PLoS One. 2023;18(1):e0269096. doi: 10.1371/journal.pone.0269096. Epub 2023 Jan 26. PMID: 36701340; PMCID: PMC9879419.
* Bento GAO, Leite VLT, Campos RP, Vaz FB, Daher EF, Duarte DB. Reduction of estimated glomerular filtration rate after COVID-19-associated acute kidney injury. J Bras Nefrol. 2023 Oct-Dec;45(4):488-494. doi: 10.1590/2175-8239-JBN-2022-0179en. PMID: 37311051; PMCID: PMC10726661.
* Zhang J, Song L, Ma Z, Sun L, Wang X, Liu D, Huang F, Man Y. Intra-abdominal pressure and residual renal function decline in peritoneal dialysis: a threshold-based investigation. Ren Fail. 2024 Dec;46(1):2312535. doi: 10.1080/0886022X.2024.2312535. Epub 2024 Feb 6. PMID: 38321869; PMCID: PMC10851793.
* Flythe JE, Watnick S. Dialysis for Chronic Kidney Failure: A Review. JAMA. 2024 Nov 12;332(18):1559-1573. doi: 10.1001/jama.2024.16338. PMID: 39356511.
* Núñez-Delgado S, Azancot MA, Méndez Fernandez AB, León-Román J, Ramos Terrades N, Toapanta N, Comas J, Sánchez-Escuredo A, Soler MJ. Long-Term Impact of Peritoneal Dialysis Ultrafiltration on Cardiorenal Patients. Cardiorenal Med. 2025;15(1):560-571. doi: 10.1159/000546924. Epub 2025 Jun 20. PMID: 40544832.
* Liu KD, Siew ED, Tuot DS, Vijayan A, Matzumura Umemoto G, Birkelo BC, Lee BJ, Kwong YD, McCoy IE, Delucchi K, Zhuo H, Hsu CY. A Conservative Dialysis Strategy and Kidney Function Recovery in Dialysis-Requiring Acute Kidney Injury: The Liberation From Acute Dialysis (LIBERATE-D) Randomized Clinical Trial. JAMA. 2026 Jan 27;335(4):326-335. doi: 10.1001/jama.2025.21530. PMID: 41201895; PMCID: PMC12595548.
* Barratt J, Eren N, Kashihara N, Maes B, Rizk DV, Rovin B, Trimarchi H, Zhang H, Wang W, Kocyigit I, Hao C, Tesař V, Turgutalp K, Yang L, Xing G, Duro Garcia V, Han SH, Lu W, Pisani A, Weinmann-Menke J, Eitner F, Guerard N, Butylin D, Monaco L, Scosyrev E, Magirr A, Renfurm R, Hach T, Perkovic V, APPLAUSE-IgAN Study Group. Iptacopan in IgA Nephropathy - Final 24-Month Data. N Engl J Med. 2026 Jul 30;395(5):465-477. doi: 10.1056/NEJMoa2600743. Epub 2026 Mar 29. PMID: 41910396.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.